Skip to the page

Data / Form D filings / Endlyz Therapeutics, Inc.

Endlyz Therapeutics, Inc.: Form D filings

Endlyz Therapeutics, Inc., a company in Boston, MA, filed 2 Form D notices with the SEC between 2021 and 2026. The latest, on May 7, 2026, reports $17.3 million sold of a $19.7 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
28 STATE STREET, Boston, MA, 02109
Phone
44 (0)7436124195
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1875514

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 7, 2026New notice$19,650,393$17,250,395$2,399,9987Mar 31, 2026sec.gov
Jul 29, 2021New notice$6,500,000$3,250,000$3,250,0006Jul 16, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joanna WolakExecutive Officer, Director
Timothy EdwardsDirector
Donmienne LeungDirector
Laurence BarkerDirector
Justian Craig FoxDirector

Other companies in Massachusetts that filed recently

Every Form D from the week of May 4, 2026 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what Endlyz Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.